ÂÜÀòÂÒÂ×

Julien Romanetto is a Regulatory Affairs Manager at Transgene, with extensive experience in regulatory development activities for investigational gene therapy medicinal products in the oncology therapeutic area since August 2011. Prior to this role, Julien served as an intern at Novartis Pharma AG, contributing to EU regulatory activities involving clinical trial initiatives and post-approval procedures, as well as supporting the pulmonary arterial hypertension program. Earlier internship experience at Bristol-Myers Squibb included involvement in national regulatory activities for oncology and hematology products, focusing on clinical trial submissions and promotional material review. Julien holds a Master 2P in International Drug Development and Registration from Paris-Sud University and a PhD from Université Henri Poincaré.